Our Funds
Seed Fund I
Established a portfolio of early stage medical device companies that looked to solve real problems.
Seed Fund II
Created investment opportunities that allowed direct engagement into company operations.
Accellerator
Continued investing in technologies that improve outcomes & reduce healthcare system costs.
Opportunity
The Opportunity Fund leverages the foundation that the cultivate(MD) Seed and Accelerator Funds have built since 2017.
Representative Investments
Embody
Embody, Inc., is a regenerative medicine company focused on the development and commercialization of implantable medical devices to address the unmet demands in soft tissue restoration and regeneration.
Imascap
Imascap develops software for preoperative planning of shoulder replacement surgery.
Shoulder Innovations
Shoulder Innovations’ InSet™ Total Shoulder Replacement System addresses the most significant issue in shoulder arthroplasty: unreliable fixation of the glenoid implant.
News and Updates
Virtual Incision Receives FDA Authorization for the First Miniaturized Robotic-Assisted Surgery Device
Grand Rapids, MI., February 27, 2024 – Virtual Incision, a cultivate(MD) portfolio company, has been granted marketing authorization of the MIRA™ Surgical System (MIRA) from the FDA.
Virtual Incision’s Mini Surgical Robot Heads to Space
The spaceMIRA, a groundbreaking surgical robot, embarks on a historic journey to the International Space Station, a collaborative effort involving the University of Nebraska and
SpinTech MRI and Canon Medical Systems USA Breaking New Ground with the Development of a Fully Quantitative Fast MRI Solution for Clinical Use
Physics-based STAGE™ quantitative output and ground truth data used with Canon AiCE (Advanced intelligent Clear-IQ Engine) deep learning reconstruction could significantly expand MRI access for
cultivate(MD) Portfolio Company NSite Medical Announces FDA Clearance
Grand Rapids, Mich., December 11, 2023 – cultivate(MD), a leader in medical device venture capital, is thrilled to announce that one of its portfolio companies, NSite
SpinTech MRI and Yale New Haven Hospital to Examine Impact of STAGE on MRI
Collaboration will assess operational and clinical impacts of STAGE through an analysis of neuroimaging efficiency, reporting workflows and clinical outcomes in actual cases. BINGHAM FARMS,
cultivate(MD) Capital Funds LP Announce Investment into Nanochon
Grand Rapids, Mich., November 27, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies with innovative technologies,